期刊
PHARMACOLOGICAL RESEARCH
卷 169, 期 -, 页码 -出版社
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.phrs.2021.105667
关键词
Rheumatoid arthritis; Berberine; Therapeutics; Targets; Gut microbiota
资金
- Project of National Natural Science Foundation of China [81861168037, 81830110, 81973745]
The study recaps the potential therapeutic effects and mechanisms of action of berberine in treating rheumatoid arthritis, as well as discusses its modulation of gut microbiota during RA. Berberine may be a promising lead drug with multi-functional activities for the therapeutic strategy of RA.
Rheumatoid arthritis is a systemic autoimmune disorder involved in persistent synovial inflammation. Berberine is a nature-derived alkaloid compound with multiple pharmacological activities in different pathologies, including RA. Recent experimental studies have clarified several determinant cellular and molecular targets of BBR in RA, and provided novel evidence supporting the promising therapeutic potential of BBR to combat RA. In this review, we recapitulate the therapeutic potential of BBR and its mechanism of action in ameliorating RA, and discuss the modulation of gut microbiota by BBR during RA. Collectively, BBR might be a promising lead drug with multi-functional activities for the therapeutic strategy of RA.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据